
Carvolix strengthens its Board of Directors, advisory board and governance structure
pharmafile | April 23, 2026 | Appointment | |Â Â CarvolixÂ
Carvolix (formerly Affluent Medical) has announced it is strengthening its Board of Directors, advisory board and governance structure.
As part of this evolution, Anne Lange has been appointed as a member of the Board of Directors, following the resignation of Soad El Gazaoui. The Company extends its sincere thanks to Soad El Gazaoui for her valuable contributions and dedicated service during her tenure.
Carvolix also announces the appointment of Rute Fernandes as Board Observer (Censeur), bringing additional strategic, operational and international expertise to the Board of Directors.
In parallel, the advisory board is reinforced with the appointment of Paul LaViolette to the Advisory Board and of Mirvat Alasnag, further strengthening the Company’s scientific, clinical and business leadership and international footprint.
Finally, Liane Teplitsky has been confirmed as Chair of the Board of Directors, while Michel Therin has been appointed Vice Chair, further strengthening the Board’s leadership structure.
Carvolix is a French commercial and clinical-stage medical technology company specialising in the international development, industrialisation and commercialisation of breakthrough AI-driven mini-robots and biomimetic implants.
Related Content

New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone
Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic …






